(Q34923038)

5 August 2017

title

Has antifungal susceptibility testing come of age? (English)

1 reference

5 August 2017

2

Michael A Pfaller

1 reference

5 August 2017

John H Rex

1

1 reference

5 August 2017

language of work or name

English

0 references

publication date

24 September 2002

1 reference

Clinical Infectious Diseases

5 August 2017

published in

1 reference

5 August 2017

volume

35

1 reference

5 August 2017

issue

8

1 reference

5 August 2017

page(s)

982-989

1 reference

ARTs versns ASTs: where are we going?

5 August 2017

cites work

1 reference

European standards for antibiotic susceptibility testing: towards a theoretical consensus

21 January 2018

1 reference

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

21 January 2018

1 reference

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

21 January 2018

1 reference

The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults.

21 January 2018

1 reference

Efficacy of amoxicillin/clavulanate for acute otitis media: relation to Streptococcus pneumoniae susceptibility

21 January 2018

1 reference

In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media

21 January 2018

1 reference

Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children

21 January 2018

1 reference

Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial.

21 January 2018

1 reference

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

21 January 2018

1 reference

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

21 January 2018

1 reference

21 January 2018

1 reference

Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group

21 January 2018

1 reference

Antifungal susceptibility testing: practical aspects and current challenges

21 January 2018

1 reference

Clinical correlates of antifungal macrodilution susceptibility test results for non-AIDS patients with severe Candida infections treated with fluconazole.

21 January 2018

1 reference

Oropharyngeal candidiasis in patients with human immunodeficiency virus: correlation of clinical outcome with in vitro resistance, serum azole levels, and immunosuppression

21 January 2018

1 reference

Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with oropharyngeal candidiasis.

21 January 2018

1 reference

Unresponsive HIV-related oro-oesophageal candidosis--an evaluation of two new in-vitro azole susceptibility tests.

21 January 2018

1 reference

Correlation of in-vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patients.

21 January 2018

1 reference

Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from Spain

21 January 2018

1 reference

Azole resistance among oral Candida species isolates from AIDS patients under ketoconazole exposure

21 January 2018

1 reference

Ketoconazole and itraconazole susceptibility of Candida albicans isolated from patients infected with HIV.

21 January 2018

1 reference

Flucytosine monotherapy for cryptococcosis.

21 January 2018

1 reference

Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy

21 January 2018

1 reference

In vivo characterization of the pharmacodynamics of flucytosine in a neutropenic murine disseminated candidiasis model

21 January 2018

1 reference

Detection of amphotericin B-resistant Candida isolates in a broth-based system

21 January 2018

1 reference

Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates

21 January 2018

1 reference

Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia.

21 January 2018

1 reference

Amphotericin B resistance testing of Candida spp.: a comparison of methods

21 January 2018

1 reference

Correlation of fluconazole MICs with clinical outcome in cryptococcal infection

21 January 2018

1 reference

In vitro susceptibility studies of Cryptococcus neoformans isolated from patients with no clinical response to amphotericin B therapy.

21 January 2018

1 reference

Antifungal drug resistance in Aspergillus

21 January 2018

1 reference

Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome

21 January 2018

1 reference

In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis.

21 January 2018

1 reference

In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B

21 January 2018

1 reference

In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans

21 January 2018

1 reference

Improved detection of amphotericin B-resistant isolates of Candida lusitaniae by Etest

21 January 2018

1 reference

Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii

21 January 2018

1 reference

Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium Prolificans Spanish Study Group.

21 January 2018

1 reference

In vitro antifungal activity of posaconazole against various pathogenic fungi

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/342384

1 reference

5 August 2017

1 reference